Pyzchiva 130 MG in 26 ML Injection
- RxCUI
- 2705564
- RxNorm name
- Pyzchiva 130 MG in 26 ML Injection
- Display name
- Pyzchiva 130 MG in 26 ML Injection
- Full name
- Pyzchiva 130 MG in 26 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
Purple Book Biologic Products#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PYZCHIVA | USTEKINUMAB-TTWE | SANDOZ INC | e8a14922-7902-4d9f-8ba5-d91dccffed29 | 2026-07-09 | Warnings, Adverse reactions | 2705564 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e8a14922-7902-4d9f-8ba5-d91dccffed29 | Pyzchiva 130 MG in 26 ML Injection [PSN] · 26 ML ustekinumab-ttwe 5 MG/ML Injection [Pyzchiva] [SBD] · 26 ML Pyzchiva 5 MG/ML Injection [SY] · Pyzchiva 130 MG per 26 ML Injection [SY] | 4 | 16 | These highlights do not include all the information needed to use PYZCHIVA safely and effectively. See full prescribing information for PYZCHIVA. PYZCHIVA ® (ustekinumab-ttwe) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 PYZCHIVA (ustekinumab-ttwe) is biosimilar* to STELARA (ustekinumab). | 20260313 |